“Public Policy”

12 result(s)
Public Policy
With a slate of bills trying to tackle rising drug prices, CVS Health advocates for those that could help increase competition and lower drug prices; others may limit private... More
Commentary
Cost Management
New GAO report shows that rebates negotiated on behalf of payors may help control premiums and provides further proof of the value PBMs bring to payors and members. More
Commentary
Placeholder
Cost Management
Dynamic forces are affecting health and pharmacy care, affordability, and access. CVS Health is aligning efforts to address these challenges with... More
Video
Public Policy
Our perspective offered to Congress on solutions and policies that can help bring escalating drug prices under control. More
Commentary
Read the article: Why the Time Is Right for a New Pricing Model
Cost Management
A Guaranteed Net Cost model can adapt to evolving market trends and help payors stay ahead of manufacturer strategies such as authorized generics, and changing legislative... More
Briefing
Public Policy
Solutions such as POS rebates and $0 copay drug lists can lower costs for plans and consumers, while a one-size-fits-all approach could lead to unintended consequences, and higher... More
Briefing
Twisting mountain road in the Swiss alps
Public Policy
Proposed HHS rule would eliminate rebates PBMs negotiate for Part D plans and MCOs, and may eventually affect all plans. Manufacturers would retain 15% of rebates currently... More
Briefing
A glass of water and two pills
Cost Management
It's time to bust the myth about drug prices and rebates. Larry Merlo, President and CEO shared CVS Health’s perspective as an employer and PBM in an op-ed. More
Commentary
Sitting man holding two pills and a glass of water
Cost Management
CVS Health responded to the Administration's Blueprint on lowering drug costs and highlighted what the company does to control costs. We also recommended things the... More
Commentary
Female patient reading the information on a prescription pill bottle
Cost Management
With prescription drug prices very much in the news, the question often asked is: Who is responsible for high drug prices? Pharmaceutical manufacturers — and no one else — set... More
Commentary